These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28706293)

  • 21. Heterogeneity of circulating tumor cells (CTCs) in patients with recurrent small cell lung cancer (SCLC) treated with pazopanib.
    Messaritakis I; Politaki E; Plataki M; Karavassilis V; Kentepozidis N; Koinis F; Samantas E; Georgoulias V; Kotsakis A
    Lung Cancer; 2017 Feb; 104():16-23. PubMed ID: 28212995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MUC1 and CD147 Are Promising Markers for the Detection of Circulating Tumor Cells in Small Cell Lung Cancer.
    Savarese-Brenner B; Heugl M; Rath B; Schweizer C; Obermayr E; Stickler S; Hamilton G
    Anticancer Res; 2022 Jan; 42(1):429-439. PubMed ID: 34969753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.
    Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C
    Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer.
    Normanno N; Rossi A; Morabito A; Signoriello S; Bevilacqua S; Di Maio M; Costanzo R; De Luca A; Montanino A; Gridelli C; Rocco G; Perrone F; Gallo C
    Lung Cancer; 2014 Aug; 85(2):314-9. PubMed ID: 24882383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.
    Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L
    Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of the role of surgery for small cell lung cancer and the potential prognostic value of enumeration of circulating tumor cells.
    Hamilton G; Rath B; Ulsperger E
    Eur J Surg Oncol; 2016 Sep; 42(9):1296-302. PubMed ID: 27402116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TSPAN12 promotes chemoresistance and proliferation of SCLC under the regulation of miR-495.
    Ye M; Wei T; Wang Q; Sun Y; Tang R; Guo L; Zhu W
    Biochem Biophys Res Commun; 2017 Apr; 486(2):349-356. PubMed ID: 28302484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of circulating tumor cells in patients with small-cell lung cancer.
    Wang YL; Liu CH; Li J; Ma XP; Gong P
    Tumori; 2017 May; 103(3):242-248. PubMed ID: 28218384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients.
    Wu C; Hao H; Li L; Zhou X; Guo Z; Zhang L; Zhang X; Zhong W; Guo H; Bremner RM; Lin P
    J Thorac Oncol; 2009 Jan; 4(1):30-6. PubMed ID: 19096303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer.
    Hamilton G; Rath B; Klameth L; Hochmair M
    Oncoscience; 2015; 2(7):629-34. PubMed ID: 26328272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
    Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
    Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy.
    Aggarwal C; Wang X; Ranganathan A; Torigian D; Troxel A; Evans T; Cohen RB; Vaidya B; Rao C; Connelly M; Vachani A; Langer C; Albelda S
    Lung Cancer; 2017 Oct; 112():118-125. PubMed ID: 29191584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic impact of circulating tumor cells in patients with small cell lung cancer.
    Naito T; Tanaka F; Ono A; Yoneda K; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Kenmotsu H; Shukuya T; Kaira K; Koh Y; Endo M; Hasegawa S; Yamamoto N
    J Thorac Oncol; 2012 Mar; 7(3):512-9. PubMed ID: 22258473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting epithelial-to-mesenchymal transition with Met inhibitors reverts chemoresistance in small cell lung cancer.
    Cañadas I; Rojo F; Taus Á; Arpí O; Arumí-Uría M; Pijuan L; Menéndez S; Zazo S; Dómine M; Salido M; Mojal S; García de Herreros A; Rovira A; Albanell J; Arriola E
    Clin Cancer Res; 2014 Feb; 20(4):938-50. PubMed ID: 24284055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating tumor cell counts/change for outcome prediction in patients with extensive-stage small-cell lung cancer.
    Cheng Y; Liu XQ; Fan Y; Liu YP; Liu Y; Liu Y; Ma LX; Liu XH; Li H; Bao HZ; Liu JJ; Zhang S; Wu CJ
    Future Oncol; 2016 Mar; 12(6):789-99. PubMed ID: 26838372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study.
    Salgia R; Weaver RW; McCleod M; Stille JR; Yan SB; Roberson S; Polzer J; Flynt A; Raddad E; Peek VL; Wijayawardana SR; Um SL; Gross S; Connelly MC; Morano C; Repollet M; Sanders R; Baeten K; D'Haese D; Spigel DR
    Invest New Drugs; 2017 Jun; 35(3):334-344. PubMed ID: 28299514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking, inflammation and small cell lung cancer: recent developments.
    Hamilton G; Rath B
    Wien Med Wochenschr; 2015 Oct; 165(19-20):379-86. PubMed ID: 26289596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.
    Inoue H; Kato T; Olugbile S; Tamura K; Chung S; Miyamoto T; Matsuo Y; Salgia R; Nakamura Y; Park JH
    Oncotarget; 2016 Mar; 7(12):13621-33. PubMed ID: 26871945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.
    Xiao F; Bai Y; Chen Z; Li Y; Luo L; Huang J; Yang J; Liao H; Guo L
    Eur J Cancer; 2014 May; 50(8):1541-54. PubMed ID: 24559685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.